Literature DB >> 15930975

Carbohydrate metabolism in uraemia.

Vincent Rigalleau1, Henri Gin.   

Abstract

PURPOSE OF REVIEW: Most uraemic patients are insulin resistant. This review focuses on the occurrence, mechanisms and consequences of this insulin resistance. Hypoglycaemia is also possible in a minority of uraemic patients; its causes are discussed at the end of the review. RECENT
FINDINGS: Insulin resistance is detectable when the glomerular filtration rate is below 50 ml/min per 1.73 m in non-diabetic uraemic individuals. Uraemia can alter insulin sensitivity even in diabetic patients; familial insulin resistance may favour the occurrence of diabetic nephropathy. Although reduced glucose non-oxidative disposal is the most evident defect of carbohydrate metabolism, abnormal glucose oxidation, endogenous glucose production and insulin secretion are also contributors. The accumulation of nitrogenous compounds is the most important mechanism of a specific state of insulin resistance in uraemia. Their identification is progressing, particularly in the field of carbamoylated amino acids. The consequences of chronic renal failure such as anaemia, metabolic acidosis and secondary hyperparathyroidism also indirectly play a role.
SUMMARY: The treatment of uraemia by renal replacement therapies or low-protein diets improves insulin sensitivity. However, patients still have a high cardiovascular risk. The identification of the accumulating molecular species that specifically alter insulin sensitivity is therefore of great interest. The favourable effect of non-specific insulin sensitizers such as glitazone may also help to reduce this risk.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930975     DOI: 10.1097/01.mco.0000172590.32564.b9

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  9 in total

1.  Pre-transplant HbA1c level as an early marker for new-onset diabetes after renal transplantation.

Authors:  Erhan Tatar; Fatih Kircelli; Meltem Sezis Demirci; Mehmet Nuri Turan; Ozkan Gungor; Gulay Asci; Mehmet Ozkahya; Ercan Ok; Cuneyt Hoscoskun; Huseyin Toz
Journal:  Int Urol Nephrol       Date:  2012-10-07       Impact factor: 2.370

2.  The impact of basal insulin analogues on glucose variability in patients with type 2 diabetes undergoing renal replacement therapy for end-stage renal disease.

Authors:  Octavian Savu; Viviana Elian; Oana Steriade; Ileana Teodoru; Stela Mihut; Catalin Tacu; Adrian Covic; Cristian Serafinceanu
Journal:  Int Urol Nephrol       Date:  2016-01-02       Impact factor: 2.370

Review 3.  Uremic toxins and lipases in haemodialysis: a process of repeated metabolic starvation.

Authors:  Bernd Stegmayr
Journal:  Toxins (Basel)       Date:  2014-04-30       Impact factor: 4.546

Review 4.  Dialysis Procedures Alter Metabolic Conditions.

Authors:  Bernd Stegmayr
Journal:  Nutrients       Date:  2017-05-27       Impact factor: 5.717

5.  Is there a relationship between serum vaspin levels and insulin resistance in chronic renal failure?

Authors:  Can Demir; Akif Dogantekin; Ali Gurel; Suleyman Aydin; Huseyin Celiker
Journal:  Pak J Med Sci       Date:  2019 Jan-Feb       Impact factor: 1.088

6.  Blood Glucose Fluctuation in Older Adults with Diabetes Mellitus and End-Stage Renal Disease on Maintenance Hemodialysis: An Observational Study.

Authors:  Jinzhu Li; Ruiqin Zhang; Zhen Wu; Jiayu Guo; Zhiying Wang; Shuhui Li; Chunlin Li; Guang Yang; Xiaoling Cheng
Journal:  Diabetes Ther       Date:  2022-06-11       Impact factor: 3.595

7.  Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis.

Authors:  Giacomo Garibotto; Antonella Sofia; Rodolfo Russo; Ernesto Paoletti; Alice Bonanni; Emanuele L Parodi; Francesca Viazzi; Daniela Verzola
Journal:  Kidney Int       Date:  2015-08-26       Impact factor: 10.612

8.  RBP4: A Culprit for Insulin Resistance in End Stage Renal Disease That Can Be Cleared by Hemodiafiltration.

Authors:  Fabrizio Grosjean; Pasquale Esposito; Rosario Maccarrone; Carmelo Libetta; Antonio Dal Canton; Teresa Rampino
Journal:  Biomed Res Int       Date:  2017-11-23       Impact factor: 3.411

9.  Effectiveness of Dose Adjustment of Insulin in Type 2 Diabetes among Hemodialysis Patients with End-Stage Renal Disease: A Randomized Crossover Study.

Authors:  Amol Singhsakul; Ouppatham Supasyndh; Bancha Satirapoj
Journal:  J Diabetes Res       Date:  2019-11-13       Impact factor: 4.011

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.